BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23680521)

  • 1. WAVE1 gene silencing via RNA interference reduces ovarian cancer cell invasion, migration and proliferation.
    Zhang J; Zhou S; Tang L; Shen L; Xiao L; Duan Z; Jia L; Cao Y; Mu X
    Gynecol Oncol; 2013 Aug; 130(2):354-61. PubMed ID: 23680521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High level of WAVE1 expression is associated with tumor aggressiveness and unfavorable prognosis of epithelial ovarian cancer.
    Zhang J; Tang L; Shen L; Zhou S; Duan Z; Xiao L; Cao Y; Mu X; Zha L; Wang H
    Gynecol Oncol; 2012 Oct; 127(1):223-30. PubMed ID: 22721732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and expression of the PRSS3 and Wiskott-Aldrich syndrome protein family verprolin-homologous protein 1 for the early detection of epithelial ovarian cancer.
    Azizmohammadi S; Safari A; Seifoleslami M; Rabati RG; Mohammadi M; Yahaghi H; Azizmohammadi S
    Tumour Biol; 2016 May; 37(5):6769-73. PubMed ID: 26662304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Yes enhances tumor migration and invasion via PI3K/AKT pathway in epithelial ovarian cancer.
    Jin Y; Huang M; Wang Y; Yi C; Deng Y; Chen Y; Jiang L; Wang J; Shen Q; Liu R; QinghuaXi
    Exp Mol Pathol; 2016 Aug; 101(1):50-7. PubMed ID: 27289010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
    Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
    Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
    Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines.
    Bai H; Li H; Li W; Gui T; Yang J; Cao D; Shen K
    Oncotarget; 2015 Sep; 6(28):25520-32. PubMed ID: 26267321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
    Xu CL; Lu XL; Yan XN; Wang HL; Chen SQ
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):134-8. PubMed ID: 22455747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA RP11-552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian cancer.
    Huang K; Geng J; Wang J
    Cancer Sci; 2018 May; 109(5):1428-1446. PubMed ID: 29478268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
    Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of microtubule-associated protein 1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton.
    Tang Z; Zhang N; Di W; Li W
    Oncol Rep; 2015 Mar; 33(3):1411-7. PubMed ID: 25607473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of the biological function on epithelial ovarian cancer with ITIH4 gene expression down-regulating in vitro].
    Huang M; Wang Q; Zhang W; Li DR; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):34-40. PubMed ID: 23531249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
    Chen S; Wu DD; Sang XB; Wang LL; Zong ZH; Sun KX; Liu BL; Zhao Y
    Cell Death Dis; 2017 Oct; 8(10):e3118. PubMed ID: 29022892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of BMI1 in epithelial ovarian cancer: investigated via the CRISPR/Cas9 system and RNA sequencing.
    Zhao Q; Qian Q; Cao D; Yang J; Gui T; Shen K
    J Ovarian Res; 2018 Apr; 11(1):31. PubMed ID: 29685168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High WAVE3 expression correlates with proliferation, migration and invasion in human ovarian cancer.
    Lu J; Wang SL; Wang YC; Wu YN; Yu X; Zhao WZ; Wang JH
    Oncotarget; 2017 Jun; 8(25):41189-41201. PubMed ID: 28476025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑139 suppressed tumor cell proliferation, migration and invasion by directly targeting HDGF in epithelial ovarian cancer.
    Liu J; Jin S; Wang R
    Mol Med Rep; 2017 Sep; 16(3):3379-3386. PubMed ID: 28713954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.